Skip to main content
SpringerLink
Log in

Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Colorectal cancer is one of the most common forms of cancer and is the third leading cause of cancer-related death worldwide. Published data on the association between CYP1A1 (MspI and Ile 462 Val) polymorphisms and colorectal cancer risk are inconclusive. To address these issues, we carried out a meta-analysis of available case–control study. Online electronic searches of PubMed were performed. We identified 17 studies (6,673 colorectal cancer patients and 8,102 control subjects) that examined the association between CYP1A1 (MspI and Ile 462 Val) polymorphisms and risk of colorectal cancer. For CYP1A1 MspI polymorphism, we performed a meta-analysis from 13 studies including 5,468 cases and 6,492 controls. Overall, there was no statistically significant association between CYP1A1 MspI polymorphism and colorectal cancer susceptibility. In the subgroup analyses based on ethnicities, no statistically significant associations were observed in all genetic models. With respect to CYP1A1 Ile 462 Val polymorphism, a total of 14 studies including 6,654 cases and 7,859 controls were involved in this meta-analysis. The CYP1A1 Ile 462 Val polymorphism was associated with risk of colorectal cancer. Ethnic subgroup analyses revealed that significant associations were found in Asians and Caucasians. In summary, this meta-analysis suggests that CYP1A1 Ile 462 Val polymorphism was a low-penetrance susceptibility gene in colorectal cancer development. On the contrary, CYP1A1 MspI polymorphism does not seem capable of modifying colorectal cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300. doi:10.3322/caac.20073

    Article  PubMed  Google Scholar 

  2. Weitz J, Koch M, Debus J, Hohler T, Galle PR et al (2005) Colorectal cancer. Lancet 365:153–165. doi:10.1016/S0140-6736(05)17706-X

    Article  PubMed  Google Scholar 

  3. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I et al (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9:489–499. doi:10.1038/nrc2645

    Article  PubMed  CAS  Google Scholar 

  4. de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4:769–780. doi:10.1038/nrc1453

    Article  PubMed  Google Scholar 

  5. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J et al (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85. doi:10.1056/NEJM200007133430201

    Article  PubMed  CAS  Google Scholar 

  6. Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P (2010) Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am J Epidemiol 172:1000–1014. doi:10.1093/aje/kwq245

    Article  PubMed  Google Scholar 

  7. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G et al (2010) SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res 38:D237–D243. doi:10.1093/nar/gkp970

    Article  PubMed  CAS  Google Scholar 

  8. Nebert DW, Russell DW (2002) Clinical importance of the cytochromes P450. Lancet 360:1155–1162. doi:10.1016/S0140-6736(02)11203-7

    Article  PubMed  CAS  Google Scholar 

  9. Nebert DW, Dalton TP (2006) The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 6:947–960. doi:10.1038/nrc2015

    Article  PubMed  CAS  Google Scholar 

  10. Wrensch MR, Miike R, Sison JD, Kelsey KT, Liu M et al (2005) CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int J Cancer 113:141–147. doi:10.1002/ijc.20537

    Article  PubMed  CAS  Google Scholar 

  11. Sivaraman L, Leatham MP, Yee J, Wilkens LR, Lau AF et al (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 54:3692–3695

    PubMed  CAS  Google Scholar 

  12. Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A et al (2005) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 15:535–546

    Article  PubMed  CAS  Google Scholar 

  13. Hayashi S, Watanabe J, Kawajiri K (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 83:866–870

    Article  PubMed  CAS  Google Scholar 

  14. Ravnik-Glavac M, Dolzan V, Breskvar K (1998) Genetic polymorphisms of xenobiotic metabolizing enzymes in human colorectal cancer. Radiol Oncol 32:35–39

    Google Scholar 

  15. Fritsche E, Bruning T, Jonkmanns C, Ko Y, Bolt HM et al (1999) Detection of cytochrome P450 1B1 Bfr I polymorphism: genotype distribution in healthy German individuals and in patients with colorectal carcinoma. Pharmacogenetics 9:405–408

    Article  PubMed  CAS  Google Scholar 

  16. Ishibe N, Stampfer M, Hunter DJ, Hennekens C, Kelsey KT (2000) A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 9:855–856

    PubMed  CAS  Google Scholar 

  17. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R et al (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23:1839–1849

    Article  PubMed  CAS  Google Scholar 

  18. Ye Z, Parry JM (2002) Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen 22:385–392. doi:10.1002/tcm.10035

    Article  PubMed  CAS  Google Scholar 

  19. Slattery ML, Samowtiz W, Ma K, Murtaugh M, Sweeney C et al (2004) CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol 160:842–852. doi:10.1093/aje/kwh298

    Article  PubMed  Google Scholar 

  20. Chen K, Jin MJ, Fan CH, Song L, Jiang QT et al (2005) A case-control study on the association between genetic polymorphisms of metabolic enzymes and the risk of colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi 26:659–664

    PubMed  Google Scholar 

  21. Little J, Sharp L, Masson LF, Brockton NT, Cotton SC et al (2006) Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case-control study in the Grampian region of Scotland. Int J Cancer 119:2155–2164. doi:10.1002/ijc.22093

    Article  PubMed  CAS  Google Scholar 

  22. Kiss I, Orsos Z, Gombos K, Bogner B, Csejtei A et al (2007) Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27:2931–2937

    PubMed  CAS  Google Scholar 

  23. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL (2007) Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci 14:183–193. doi:10.1007/s11373-006-9139-x

    Article  PubMed  CAS  Google Scholar 

  24. Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K et al (2007) Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev 8:438–444

    PubMed  Google Scholar 

  25. Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K et al (2009) Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case-control study in Japan. Scand J Gastroenterol 44:952–959. doi:10.1080/00365520902964721

    Article  PubMed  CAS  Google Scholar 

  26. Nisa H, Kono S, Yin G, Toyomura K, Nagano J et al (2010) Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. BMC Cancer 10:274. doi:10.1186/1471-2407-10-274

    Article  PubMed  Google Scholar 

  27. Rohlfs RV, Weir BS (2008) Distributions of Hardy–Weinberg equilibrium test statistics. Genetics 180:1609–1616. doi:10.1534/genetics.108.088005

    Article  PubMed  CAS  Google Scholar 

  28. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. doi:10.1002/sim.1186

    Article  PubMed  Google Scholar 

  29. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748

    PubMed  CAS  Google Scholar 

  30. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  31. Tobias A (1999) Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 8:15–17

    Google Scholar 

  32. Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J (2005) A method for meta-analysis of molecular association studies. Stat Med 24:1291–1306. doi:10.1002/sim.2010

    Article  PubMed  Google Scholar 

  33. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  PubMed  CAS  Google Scholar 

  34. Sergentanis TN, Economopoulos KP (2010) Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122:459–469. doi:10.1007/s10549-009-0694-5

    Article  PubMed  CAS  Google Scholar 

  35. Jin JQ, Hu YY, Niu YM, Yang GL, Wu YY et al (2011) CYP1A1 Ile462Val polymorphism contributes to colorectal cancer risk: a meta-analysis. World J Gastroenterol 17:260–266

    Article  PubMed  CAS  Google Scholar 

  36. Masson LF, Sharp L, Cotton SC, Little J (2005) Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 161:901–915. doi:10.1093/aje/kwi121

    Article  PubMed  CAS  Google Scholar 

  37. Quinones L, Lucas D, Godoy J, Caceres D, Berthou F et al (2001) CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35–44

    Article  PubMed  CAS  Google Scholar 

  38. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45–61

    Article  PubMed  CAS  Google Scholar 

  39. Kaklamani VG, Hou N, Bian Y, Reich J, Offit K et al (2003) TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. J Clin Oncol 21:3236–3243. doi:10.1200/JCO.2003.11.524

    Article  PubMed  CAS  Google Scholar 

  40. Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16:2533–2547. doi:10.1158/1055-9965.EPI-07-0708

    Article  PubMed  Google Scholar 

  41. Boland CR (2010) Chronic inflammation, colorectal cancer and gene polymorphisms. Dig Dis 28:590–595. doi:10.1159/000320053

    Article  PubMed  Google Scholar 

  42. Din FV, Theodoratou E, Farrington SM, Tenesa A, Barnetson RA et al (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut 59:1670–1679. doi:10.1136/gut.2009.203000

    Article  PubMed  CAS  Google Scholar 

  43. Rheem DS, Baylink DJ, Olafsson S, Jackson CS, Walter MH (2010) Prevention of colorectal cancer with vitamin D. Scand J Gastroenterol 45:775–784. doi:10.3109/00365521003734125

    Article  PubMed  CAS  Google Scholar 

  44. Arain MA, Abdul Qadeer A (2010) Systematic review on “vitamin E and prevention of colorectal cancer”. Pak J Pharm Sci 23:125–130

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Center for Disease Control and Prevention of Shaanxi Province, 3Jiandong Road, 710054, Shaanxi, Xi’an, People’s Republic of China

    Yuan Zheng, Jing-Jun Wang & Hong-Lei Li

  2. Department of Center for Disease Control and Prevention of Fuyang, Fuyang, China

    Liang Sun

Authors
  1. Yuan Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jing-Jun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liang Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hong-Lei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing-Jun Wang.

Additional information

Yuan Zheng, Liang Sun and Hong-Lei Li contributed equally to this work, should be considered as co-first authors.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zheng, Y., Wang, JJ., Sun, L. et al. Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep 39, 3533–3540 (2012). https://doi.org/10.1007/s11033-011-1126-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-1126-2

Keywords

Search

Navigation